{"id":69313,"name":"FRESENIUS KABI","slug":"fresenius-kabi","state":"IL","country":"United States of America","description":"Development and production of essential medicines, biologics, and nutrition products.","totalSpending":75000,"filings":3,"yearlySpending":[{"year":2025,"income":75000}],"issues":[{"code":"TAR","display":"Tariff (miscellaneous tariff bills)"},{"code":"MAN","display":"Manufacturing"},{"code":"HCR","display":"Health Issues"}],"firms":["EAST END GROUP, LLC"],"lobbyists":["ANDREW HAWKINS","KELLY CHILDRESS LANGE"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office","Commerce, Dept of (DOC)"],"sampleDescriptions":["Buy America legislation, tariffs, regulatory incentives for domestic manufacturing, and Section 232 investigation into pharmaceuticals and unfair trade practices.","Buy America legislation, tariffs, regulatory incentives for domestic manufacturing, and Section 232 investigation into pharmaceuticals and unfair trade practices.","Buy America legislation, tariffs, regulatory incentives for domestic manufacturing, and Section 232 investigation into pharmaceuticals and unfair trade practices.","Funding and incentives for domestic manufacturing. Regulatory and legislative issues related to on-shoring and procurement of sterile injectable products and related medical devices.","Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing."]}